KPRX Stock Analysis: Buy, Sell, or Hold?
KPRX - Kiora Pharmaceuticals, Inc. Common Stock
$2.46
-0.05 (-1.99%)
▼
5d:
-3.53%
30d:
-6.46%
90d:
-0.4%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 14, 2026
30d
Get Alerted When KPRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KPRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KPRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KPRX is currently trading at $2.46, which is considered oversold relative to its 30-day fair value range of $2.51 to $2.62.
Technical Outlook: Technically, KPRX is in a strong uptrend. The price is currently testing key support at $2.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KPRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.00 (+387.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KPRX is in a strong uptrend. The price is currently testing key support at $2.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KPRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.00 (+387.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.51 -
$2.62
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 387.8% below Wall St target ($12.00)
Trading Range Analysis
30-Day Trading Range
$2.51 -
$2.62
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.46
Resistance Level
$2.88
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.25
Wall Street Target
$12.00
(+387.8%)
Share & Embed Analysis
Last updated: July 14, 2026 1:21 AM ET
Data refreshes hourly during market hours. Next update: 2:21 AM
Data refreshes hourly during market hours. Next update: 2:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KPRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 56 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 50 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 45 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 51 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
